Sichuan Airlines to resume operations to India from May 9, says Pharmexcil

Published On 2021-05-07 04:30 GMT | Update On 2021-05-07 08:33 GMT

Hyderabad: China''s state-run Sichuan Airlines, which had suspended its cargo operations to India following the second wave of COVID-19, will restart services from May 9, a top official of Pharmaceuticals Export Promotion Council of India (Pharmexcil) said on Thursday.

Recently, the Pharmexcil had sought the intervention of Indian Ambassador in China into the supply disruption caused by the suspension ofair cargo services of the airlines to India, for 15 days.

"Reference is invited to the above-mentioned subject. In this regard, I am directed to inform that Sichuan Airlines is restarting its operations from Chengdu to Chennai from 12th May, and from Chengdu to Bengaluru on 9th May 2021, Director General of Pharmexcil, Udaya Bhaskar told PTI quoting an email from the Department of Pharmaceuticals.

Sichuan Airlines had announced the suspension of all its cargo flights to India, causing major disruption to private traders'' efforts to procure the much-needed oxygen concentrators and other medical supplies from China. This was despite Beijing offering "support and assistance" to India to deal with the latest surge of COVID- 19 cases. In addition to Sichuan Airlines, there are multiple other cargo operations available from China to India including charter flights, the DoP reply said.

According to Udaya Bhaskar, India sources almost 60 to 70 per cent of its requirements of drug intermediates, key starting materials and active pharmaceutical ingredients (API) from China and most importantly 45 to 50 per cent of all APIs imported figure in the National List of Essential Medicines.

Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Sichuan Airlines to resume operations to India from May 9, says Pharmexcil

Similar News

Wockhardt Misses NPPA Clearance for Nafithromycin, Faces Questions on Patent Validity

Ajanta Pharma Told to Revise BE Study Protocol for Cilnidipine, Metoprolol FDC

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

SC doors knocked for child deaths linked to contaminated cough syrup, CBI probe demanded

AstraZeneca Pharma India bags CDSCO nod for expanded use of Trastuzumab Deruxtecan in HER2-Positive Solid Tumors

Coldrif Cough Syrup banned in Punjab amid child deaths

Contaminated cough syrup tragedy: NHRC steps in, demands investigation

DoP identifies 11,100 Jan Aushadhi Kendras across India as Outdoor Cleaning Sites